PharmEasy plans to raise ₹ 6,250 crore through its public issue. The company will use this capital to acquire new businesses and repay loans. Its consolidated revenue tripled to ₹2360 crore in ...
As six-year-old tech unicorn PharmEasy acquires publicly-listed diagnostics chain Thyrocare, many believe it is a pivotal moment for startups in India CEO Siddharth Shah says the strong bond ...
BENGALURU, India, Aug. 23, 2022 /PRNewswire/ -- Cashfree Payments, one of India's leading payments and API banking solutions companies, has partnered with PharmEasy, one of India's leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback